99

Breakthroughs
Sub Categories on Breakthroughs
Latest Articles
The double-edge sword of CRISPR application for in vivo studies

The double-edge sword of CRISPR application for in vivo studies

by Impact Journals LLCWorkflow illustration. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28459A new editorial paper titled "The double-edge sword of CRISPR application for in vi

The double-edge sword of CRISPR application for in vivo studies

by Impact Journals LLCWorkflow illustration. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28459A new editorial paper titled "The double-edge sword of CRISPR application for in vi
The fate of drug discovery in academia: Why is it so difficult?

The fate of drug discovery in academia: Why is it so difficult?

FEBRUARY 5, 2024by Impact Journals LLCA typical drug discovery and development strategy. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28552A new editorial paper titled "The fate

The fate of drug discovery in academia: Why is it so difficult?

FEBRUARY 5, 2024by Impact Journals LLCA typical drug discovery and development strategy. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28552A new editorial paper titled "The fate
Cloud-magnetic resonance imaging system in the 6G and AI era

Cloud-magnetic resonance imaging system in the 6G and AI era

by KeAi Communications Co.The workflow of Cloud-MRI system. Credit: Yirong Zhou., et alMagnetic resonance imaging (MRI) has played an important role in modern medical diagnosis, generating petabytes o

Cloud-magnetic resonance imaging system in the 6G and AI era

by KeAi Communications Co.The workflow of Cloud-MRI system. Credit: Yirong Zhou., et alMagnetic resonance imaging (MRI) has played an important role in modern medical diagnosis, generating petabytes o
Researchers shed light on the molecular causes of different functions of opioid receptors

Researchers shed light on the molecular causes of different functions of opioid receptors

by Anne Grimm,Leipzig UniversityLigand-dependent activation of the µOR.a, Binding of agonist to the µOR activates two downstream signaling pathways: the G-protein pathway and the β-arresti

Researchers shed light on the molecular causes of different functions of opioid receptors

by Anne Grimm,Leipzig UniversityLigand-dependent activation of the µOR.a, Binding of agonist to the µOR activates two downstream signaling pathways: the G-protein pathway and the β-arresti
Study reveals insights into diabetic kidney disease and how anti-obesity drugs work

Study reveals insights into diabetic kidney disease and how anti-obesity drugs work

by Monash UniversityThis image shows a cross section of a kidney. Credit: Holly Fischer/WikipediaData from Australian researchers could partly explain why a trial of a new drug for diabetes, was

Study reveals insights into diabetic kidney disease and how anti-obesity drugs work

by Monash UniversityThis image shows a cross section of a kidney. Credit: Holly Fischer/WikipediaData from Australian researchers could partly explain why a trial of a new drug for diabetes, was
Research sheds light on effectiveness of FDA's black box warning for asthma drug

Research sheds light on effectiveness of FDA's black box warning for asthma drug

by University of OklahomaCredit: Pixabay/CC0 Public DomainA University of Oklahoma study about a "black box warning" for the asthma drug Singulair continues to influence a national conv

Research sheds light on effectiveness of FDA's black box warning for asthma drug

by University of OklahomaCredit: Pixabay/CC0 Public DomainA University of Oklahoma study about a "black box warning" for the asthma drug Singulair continues to influence a national conv
ASH: Daratumumab beneficial for patients with multiple myeloma

ASH: Daratumumab beneficial for patients with multiple myeloma

by Elana GotkineFor transplantation-eligible patients with newly diagnosed multiple myeloma, the addition of subcutaneous daratumumab combined with bortezomib, lenalidomide, and dexamethasone inductio

ASH: Daratumumab beneficial for patients with multiple myeloma

by Elana GotkineFor transplantation-eligible patients with newly diagnosed multiple myeloma, the addition of subcutaneous daratumumab combined with bortezomib, lenalidomide, and dexamethasone inductio
Study finds Paxlovid treatment does not reduce risk of long COVID

Study finds Paxlovid treatment does not reduce risk of long COVID

byUniversity of California, San FranciscoIn all models, treatment with oral nirmatrelvir was not associated with lower odds of patient reported Long COVID symptoms with confidence intervals that

Study finds Paxlovid treatment does not reduce risk of long COVID

byUniversity of California, San FranciscoIn all models, treatment with oral nirmatrelvir was not associated with lower odds of patient reported Long COVID symptoms with confidence intervals that
Researchers design novel drug delivery system that could reverse Alzheimer's disease impact

Researchers design novel drug delivery system that could reverse Alzheimer's disease impact

FEBRUARY 21, 2024byUniversity of North Carolina at Chapel HillChirality inversion mechanisms. Scheme and TEM images (a) of Fmoc-FFFF-PEG2 prepared at RT, or heated to 37 and 40 °C to track the c

Researchers design novel drug delivery system that could reverse Alzheimer's disease impact

FEBRUARY 21, 2024byUniversity of North Carolina at Chapel HillChirality inversion mechanisms. Scheme and TEM images (a) of Fmoc-FFFF-PEG2 prepared at RT, or heated to 37 and 40 °C to track the c
Epilepsy drug shows promise in slowing joint degeneration in osteoarthritis

Epilepsy drug shows promise in slowing joint degeneration in osteoarthritis

by Yale Universitya, Safranin O and Fast Green-stained sections of knee joints of mice with the indicated genotype (n = 8). Scale bar, 50 µm.b–e, OARSI score (b), osteophyte development (c)

Epilepsy drug shows promise in slowing joint degeneration in osteoarthritis

by Yale Universitya, Safranin O and Fast Green-stained sections of knee joints of mice with the indicated genotype (n = 8). Scale bar, 50 µm.b–e, OARSI score (b), osteophyte development (c)